Related Experiment Video

Updated: Aug 8, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Treatment with inhaled corticosteroids improves pulmonary function in children under 2 years old with risk factors

Alejandro Manuel Teper1, Carlos Daniel Kofman

  • 1Respiratory Center, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina. ateper@intramed.net

Current Opinion in Allergy and Clinical Immunology
|May 4, 2006
PubMed

Insights

Inhaled corticosteroids improve pulmonary function and illness control in young children with asthma. Evidence suggests early treatment for recurrent wheeze can prevent severe disease and irreversible obstruction.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Clinical Immunology

Background:

  • Asthma is a chronic respiratory condition affecting children worldwide.
  • Persistent asthma in children requires effective management to prevent long-term complications.
  • Inhaled corticosteroids (ICS) are a cornerstone therapy for pediatric asthma.

Purpose of the Study:

  • To review recent studies on the impact of inhaled corticosteroids on pulmonary function in young children with asthma.
  • To synthesize current evidence regarding the efficacy of ICS in improving lung function in pediatric asthma patients.
  • To address the existing discrepancies in research findings concerning ICS effectiveness in early childhood asthma.

Main Methods:

  • Systematic review of recent clinical studies and research publications.
  • Analysis of data from trials investigating inhaled corticosteroids in infants and young children.
  • Evaluation of studies focusing on pulmonary function tests and clinical outcomes in pediatric asthma.

Main Results:

  • Inhaled corticosteroids are widely recognized as the most effective treatment for persistent childhood asthma.
  • Recent studies indicate a demonstrable improvement in pulmonary function in young children using ICS.
  • Despite some conflicting results, evidence suggests ICS ameliorate clinical outcomes in pediatric asthma.

Conclusions:

  • Inhaled corticosteroids are recommended for infants and young children with recurrent wheeze and asthma risk factors.
  • Early ICS treatment appears to enhance illness control and improve pulmonary function in this age group.
  • Consistent application of ICS may prevent the progression to more severe asthma and irreversible airway obstruction.
Abstract

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: